医科学研究センター

研究成果

年別の研究成果 1981 2008 2009 2010 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 28451 被引用数
• 84 h 指数
• 630 学術論文
• 51 総説
• 16 コメント/討論
• 10 Letter
• 17 その他
  • 8 章
  • 6 簡易調査
  • 3 編集

年別の研究成果

年別の研究成果

検索結果

• 2020

  Regulatory Roles of Long Non-coding RNAs in Skeletal Muscle Differentiation, Regeneration, and Disorders

  Hitachi, K. & Tsuchida, K., 2020, RNA Technologies. Springer Science and Business Media Deutschland GmbH, p. 431-463 33 p. (RNA Technologies; vol. 11).

  研究成果: 書籍/レポート タイプへの寄稿 › 章

  • Skeletal Muscle 100%
  • Myogenesis 100%
  • Long Noncoding RNA 100%
  • Long Non-Coding RNA 100%
  • Muscle Development 100%
  4 被引用数 (Scopus)
• 2019

  Disruption of the responsible gene in a phosphoglucomutase 1 deficiency patient by homozygous chromosomal inversion

  Yokoi, K., Nakajima, Y., Ohye, T., Inagaki, H., Wada, Y., Fukuda, T., Sugie, H., Yuasa, I., Ito, T. & Kurahashi, H., 2019, JIMD Reports. Springer, p. 85-90 6 p. (JIMD Reports; vol. 43).

  研究成果: 書籍/レポート タイプへの寄稿 › 章

  Open Access

  • Chromosomal Inversion 100%
  • Phosphoglucomutase 100%
  • Phosphoglucomutase 1 Deficiency 100%
  • Patient Phenotype 20%
  • Biochemical Diagnosis 20%
  9 被引用数 (Scopus)
• 2018

  Clinical consequences of chromothripsis and other catastrophic cellular events

  Fukami, M. & Kurahashi, H., 2018, Methods in Molecular Biology. Humana Press Inc., p. 21-33 13 p. (Methods in Molecular Biology; vol. 1769).

  研究成果: 書籍/レポート タイプへの寄稿 › 章

  • Chromothripsis 100%
  • Clinical Consequences 100%
  • Cellular Events 100%
  • Germ Cells 50%
  • Catastrophic Events 50%
  10 被引用数 (Scopus)
• 2016

  Identification, isolation, and characterization of mesenchymal progenitors in mouse and human skeletal muscle

  Uezumi, A., Kasai, T. & Tsuchida, K., 2016, Methods in Molecular Biology. Humana Press Inc., p. 241-253 13 p. (Methods in Molecular Biology; vol. 1460).

  研究成果: 書籍/レポート タイプへの寄稿 › 章

  • Mouse 100%
  • Skeletal Muscle 100%
  • Stem Cell 33%
  • Muscle Regeneration 33%
  • Fluorescence Activated Cell Sorting 33%
  19 被引用数 (Scopus)

• The role of myostatin and related factors in muscle hypertrophy and atrophy

  Tsuchida, K., Hitachi, K., Nakatani, M., Uezumi, A. & Ageta, H., 01-01-2016, Myostatin: Structure, Role in Muscle Development and Health Implications. Nova Science Publisher Inc., p. 1-13 13 p.

  研究成果: 書籍/レポート タイプへの寄稿 › 章

  • Myostatin 100%
  • Muscle Atrophy 100%
  • Muscle Hypertrophy 100%
  • Skeletal Muscle 57%
  • Activin 23%
• 2014

  Characterization of Inorganic Nanomaterials as Therapeutic Vehicles

  Murakami, T., Yudasaka, M., Iijima, S. & Tsuchida, K., 01-01-2014, Recent Advances in Medicinal Chemistry. Elsevier Inc., Vol. 1. p. 73-98 26 p.

  研究成果: 書籍/レポート タイプへの寄稿 › 章

  • Therapeutic Vehicle 100%
  • Inorganic Nanomaterials 100%
  • Adverse Drug Effects 25%
  • Organic Nanomaterials 25%
  • Gold Nanoparticles 25%
  2 被引用数 (Scopus)
• 2013

  Cruciform DNA

  Inagaki, H. & Kurahashi, H., 27-02-2013, Brenner's Encyclopedia of Genetics: Second Edition. Elsevier Inc., p. 241-243 3 p.

  研究成果: 書籍/レポート タイプへの寄稿 › 章

  • Crossover Junction Endodeoxyribonuclease 100%
  • Recombination Intermediates 33%
  • Specific Enzymes 33%
  • Structure-specific 33%
  • Superhelicity 33%
  3 被引用数 (Scopus)
• 2012

  In Vitro Splicing Assays

  Mayeda, A. & Krainer, A. R., 02-02-2012, Alternative pre-mRNA Splicing: Theory and Protocols. Wiley-VCH, p. 320-329 10 p.

  研究成果: 書籍/レポート タイプへの寄稿 › 章

  • Cis Acting Element 100%
  • Trans Acting Factor 100%
  • Trans-Acting Factor 100%
  • Denaturing Polyacrylamide Gel Electrophoresis 50%
  • Defined Conditions 50%
  6 被引用数 (Scopus)